Primary Intracranial Leiomyosarcoma: Report of a Case and Review of the Literature by Hussain, Sakeer et al.
Hindawi Publishing Corporation
Sarcoma
Volume 2006, Article ID 52140, Pages 1–3
DOI 10.1155/SRCM/2006/52140
CaseReport
Primary Intracranial Leiomyosarcoma: Report of
a Case and Review of the Literature
Sakeer Hussain,1 Anil Nanda,2 Marjorie Fowler,3 Federico L. Ampil,4 and Gary V. Burton1
1Department of Medicine, Feist Weiller Cancer Center, Louisiana State University Health Science Center - Shreveport,
1501 Kings Highway, Shreveport, LA 71130, USA
2Department of Neurosurgery, Feist Weiller Cancer Center, Louisiana State University Health Science Center - Shreveport,
1501 Kings Highway, Shreveport, LA 71130, USA
3Department of Pathology, Feist Weiller Cancer Center, Louisiana State University Health Science Center - Shreveport,
1501 Kings Highway, Shreveport, LA 71130, USA
4Department of Radiology, Feist Weiller Cancer Center, Louisiana State University Health Science Center - Shreveport,
1501 Kings Highway, Shreveport, LA 71130, USA
Received 29 June 2006; Revised 13 October 2006; Accepted 13 October 2006
A 26-year old man presented with a 3-month history of a progressively enlarging palpable parieto-occipital mass. A CT scan indi-
catedthelesionarosefromthedurawithbonydestruction.Astealthassistedcraniotomywasperformedwiththeprovisionaldiag-
nosis of osteoblastic meningioma. Further histopathologic analysis of the intracranial mass was consistent with leiomyosarcoma.
Staging evaluation, including CT and PET scans, demonstrated no other sites of disease. Despite complete surgical resection and
radiotherapy to the resection site, the disease recurred locally and systematically 5 months later. Primary intracranial mesenchy-
mal tumors are rare and few cases have been previously reported. Outcomes have been universally poor and current therapeutic
approaches appear to have only limited beneﬁt.
Copyright © 2006 Sakeer Hussain et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Intracranial neoplasms of mesenchymal origin are uncom-
mon. The majority of these tumors represent metastatic dis-
ease from other primary sites. Primary intracranial soft tis-
sue sarcomas can, however, arise from mesenchymal cells
of the dura matter or the cerebral blood vessels. These tu-
morsoftenmimicmeningiomaonpreoperativeMRIand,al-
though rare, should be included in the diﬀerential diagnosis
ofdural-basedlesions.Immunohistochemicalstainscanhelp
distinguishing these tumors from meningiomas. Postopera-
tive radiation and chemotherapy should be considered, how-
ever,theprognosishasbeenuniversallypoor.Wedescribethe
course of a patient with a primary intracranial leiomyosar-
coma and review the literature.
CASE HISTORY
A 26-year old previously healthy male presented with a 3
month history of progressively enlarging parieto-occipital
mass. There were no constitutional or neurological symp-
toms and no symptoms suggestive of other sites of involve-
ment. There was no history of smoking, IV drug abuse, or
sexual promiscuity. Physicalexamination was remarkable for
apalpable5cm,ﬁxed,nontendermassovertherightparieto-
occipitalregion.Completebloodcountsandmetabolicpanel
werenormal.Viralserologywasnegativeforbothhumanim-
mune deﬁciency virus (HIV) and Epstein-Barr virus (EBV).
A CT scan of the brain demonstrated a large highly vascu-
lar soft tissue mass involving the meninges with invasion of
the parietal bone and displacement of the brain parenchyma
(Figure 1). A clinical diagnosis of osteoblastic meningioma
was made. The patient underwent an uncomplicated stealth
assisted craniotomy with cranioplasty and gross microsur-
gical resection of the tumor. The tumor involved the dura
mater and had eroded through the bony skull. The surgical
margins were negative. The histologic examination demon-
strated a malignant spindle cell neoplasm with immunos-
tains positive for smooth muscle actin and negative for ep-
ithelial membrane antigen (Figure 2). Pathologic interpreta-
tion was a malignant spindle cell neoplasm consistent with
high grade leiomyosarcoma with myxoid and epitheloid ar-
eas. Staging CT scan of the chest, abdomen and pelvis and
PET scan were negative for other sites of involvement. The2 Sarcoma
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Figure 1:CTscanoftheheadshowsalargevascularsofttissuemass
involving the meninges and invasion of right parietal bone.
patient received radiation therapy consisting of 61.8Gyin34
fractions using involved ﬁeld (tumor bed) megavoltage irra-
diation. Adjuvant chemotherapy was declined by the patient.
Fivemonthsfollowingthesurgerythepatientdevelopedpain
in the right hip. An MRI of the right hip showed hetero-
geneous marrow replacement in the right ischium extend-
ing to the acetabular marrow, with extraosseous soft tissue
component and small ipsilateral joint eﬀusion. A CT scan
showed multiple lung lesions and a 2.5cm liver lesion. An
MRI of the brain revealed a suspicious small residual area at
the parieto-occipital extradural space. Fine needle aspiration
of the lung mass was performed and cytology was consistent
with leiomyosarcoma. The patient initially declined systemic
chemotherapy, but subsequently received liposomal doxoru-
bicin without response. He died 7 months after the initial
diagnosis.
DISCUSSION
Softtissuesarcomasareraretumorsandaccountforonlyone
percent of all cancers [1]. Most intracranial soft tissue sarco-
mas represent metastatic disease. Primary intracranial sarco-
mas are extremely rare [2]. Intracranial sarcomas appear to
originate from leptomeningeal lining and usually have du-
ral attachment [3]. Pleuripotent mesenchymal stem cells in
the dura are probably the cells of origin. Intracerebral sar-
comas may also arise from cerebral blood vessel epithelium
[4].Thesetumorsmayalsooriginateinthebloodvesselsout-
side the dural surface and extend to the skull and meninges.
There was no deﬁnite evidence to conﬁrm the origin of tu-
mor in this case but involvement of the dura with invasion of
the skull suggests a dural origin.
An increased incidence of leiomyoma and leiomyosar-
coma has been observed in immunocompromised patients.
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Figure 2: (a) Malignant spindle cells, pleomorphism, and high nu-
cleocytoplasmic ratio. (b) Immunostain positive for smooth muscle
actin.
The association of these neoplasms with Epstein-Barr virus
infection and AIDS is well documented in the literature
[5, 6]. Our patient, however, had negative serology for both
HIV and EBV infections. Radiation exposure has also been
associated with an increased incidence of various soft tis-
sue sarcomas. Intracranial leiomyosarcoma was reported 23
years after radiation treatment for a pituitary adenoma [7].
Our review of primary intracranial myomatous tumors
found that only one out of 29 reported cases demonstrated
smooth muscle diﬀerentiation. The other cases were pure
mesenchymal or mixed neural and mesenchymal tumors
showing skeletal muscle diﬀerentiation. Tumors with rhab-
domyomatous elements were more common than tumors
containing leiomyosarcomatous characteristics [8].
In another study of 3829 patients with soft tissue sar-
coma, 21 patients presented with and 19 patients subse-
quently developed brain metastases. In this study the most
frequent tumor type with metastatic brain involvement was
leiomyosarcoma [9]. Leiomyosarcomas, however, tend to ex-
hibit hematogenous spread to lung prior to the appearance
of brain metastases and, the metastasis usually involves brain
parenchyma [9, 10].Sakeer Hussain et al 3
The diagnosis of leiomyosarcoma is conﬁrmed by ul-
trastructural features of smooth muscle cells and immuno-
histochemistry. The tumor cells are elongated with taper-
ing cytoplasmic processes with elongated, convoluted nu-
clei, pinocytic vesicles, and basement membrane material
around the cytoplasmic membrane. The diﬀerential diag-
noses, which include malignant astrocytoma, malignant ﬁ-
brous histocytoma, and meningioma, were excluded by im-
munohistochemical testing. Our patient’s tumor was nega-
tive for S-100 protein and epithelial membrane antigen and
positive for smooth muscle actin and cytokeratin staining.
Although the pathologic and radiographic examination
indicated a primary intracranial leiomyosarcoma in our pa-
tient, another primary site could not be excluded with com-
plete certainty. Within the limits of CT scan and other imag-
ing modalities, the evaluation and the clinical course of our
patient were consistent with a primary intracranial location.
The prognosis for primary intracranial leiomyosarcoma
is poor with the longest reported survival being 32 months
[9, 11] .P a t i e n ts u r v i v a li sp r o b a b l yl i m i t e db yt h ed i ﬃculty
in obtaining adequate surgical margins and an adequate ra-
diation therapydose to the intracranial location. Intracranial
and meningeal tumor spread may also limit the beneﬁts of
systemic adjuvant chemotherapy. Despite these limitations,
treatment should probably include aggressive application of
multimodality therapy.
A primary intracranial tumor of mesodermal origin is
rare and the majority of these tumors are rhabdomyosar-
coma. Leiomyosarcomas may mimic meningiomas on pre-
operative MRI and, although extremely rare, must be in-
cluded in the diﬀerential diagnosis of dural-based lesions
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